Combination of Tenofovir and Emtricitabine with Efavirenz Does Not Moderate Inhibitory Effect of Efavirenz on Mitochondrial Function and Cholesterol Biosynthesis in Human T Lymphoblastoid Cell Line

Antimicrobial Agents and Chemotherapy
Min LiElijah Paintsil

Abstract

Efavirenz (EFV), the most popular nonnucleoside reverse transcriptase inhibitor, has been associated with mitochondrial dysfunction in most in vitro studies. However, in real life the prevalence of EFV-induced mitochondrial toxicity is relatively low. We hypothesized that the agents given in combination with EFV moderate the effect of EFV on mitochondrial function. To test this hypothesis, we cultured a human T lymphoblastoid cell line (CEM cells) with EFV alone and in combination with emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) to investigate the effects on mitochondrial respiration and function and cholesterol biosynthesis. There was a statistically significant concentration- and time-dependent apoptosis, reduction in mitochondrial membrane potential, and increase in production of reactive oxygen species in cells treated with either EVF alone or in combination with TDF plus FTC. Compared to dimethyl sulfoxide-treated cells, EFV-treated cells had significant reduction in oxygen consumption rate contributed by basal mitochondrial respiration and decreased protein expression of electron transport chain complexes (CI, CII, and CIV). Treatment with EFV resulted in a decrease in mitochondrial DNA content and perturb...Continue Reading

References

May 1, 1995·Nature Medicine·W Lewis, M C Dalakas
May 3, 2003·Cell Death and Differentiation·J-E RicciD R Green
May 27, 2003·Apoptosis : an International Journal on Programmed Cell Death·J D LyA Lawen
Jan 27, 2007·The Journal of Antimicrobial Chemotherapy·Antonio RiveroJuan A Pineda
May 2, 2007·Antimicrobial Agents and Chemotherapy·Kaleb C LundKendall B Wallace
May 7, 2009·AIDS·Richard H HaubrichUNKNOWN AIDS Clinical Trials Group (ACTG) A5142 Study Team
Sep 23, 2009·AIDS·UNKNOWN HIV-CAUSAL CollaborationMiguel A Hernán
Feb 24, 2010·AIDS·Jacqueline NeuhausUNKNOWN INSIGHT SMART and ESPRIT study groups
Jun 22, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ana Blas-GarcíaJuan V Esplugues
Jul 20, 2010·The Journal of Antimicrobial Chemotherapy·Daniel F CarrClaudia P Cortes
Aug 26, 2010·Journal of Molecular and Cellular Cardiology·Wu DengClive M Baumgarten
Oct 23, 2010·The International Journal of Neuroscience·G I T CavalcanteM M F Fonteles
Nov 17, 2010·Antimicrobial Agents and Chemotherapy·Elijah PaintsilYung-Chi Cheng
Apr 13, 2011·AIDS and Behavior·Christopher A Kenedi, Harold W Goforth
Jul 6, 2011·The Biochemical Journal·Martin D Brand, David G Nicholls
Sep 9, 2011·Trends in Pharmacological Sciences·Nadezda ApostolovaJuan V Esplugues
Sep 10, 2011·The Journal of Antimicrobial Chemotherapy·Karin NeukamUNKNOWN SEGURIDAD HEPÁTICA Study Team of the Grupo HEPAVIR de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI)
Jun 22, 2012·Journal of Aging Research·Claus DeslerLene Juel Rasmussen
Sep 25, 2012·HIV Medicine·R WeberUNKNOWN Swiss HIV Cohort Study (SHCS)
Mar 27, 2013·Laboratory Investigation; a Journal of Technical Methods and Pathology·Balu K ChackoVictor M Darley-Usmar
Apr 18, 2014·The Journal of Antimicrobial Chemotherapy·Alejandro Gonzalez-SernaRichard Harrigan
Nov 9, 2014·Journal of Biomolecular Screening·Ruolan WangJulie B Stimmel
May 1, 2015·The Journal of Antimicrobial Chemotherapy·Haryes A FunesNadezda Apostolova
Aug 5, 2015·Experimental Cell Research·Lara GibelliniAndrea Cossarizza
Feb 13, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Antonio Di BiagioUNKNOWN ICONA Foundation Study Group
Jul 28, 2016·Clinical and Translational Medicine·Vicent RibasJosé C Fernández-Checa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Related Papers

Expert Opinion on Drug Metabolism & Toxicology
Natella Y Rakhmanina, John N van den Anker
Journal of Acquired Immune Deficiency Syndromes : JAIDS
Anita A MathiasEfavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen Development Team
© 2022 Meta ULC. All rights reserved